Development of Okra-Based Antidiabetic Nutraceutical Formulation from Abelmoschus esculentus (L.) Moench (Ex-maradi Variety) doi.org/10.26538/tjnpr/v2i2.5
Main Article Content
Abstract
Diabetes mellitus is a complex metabolic disorder that is considered a worldwide epidemic and is associated with the development of many complications. Okra fruit is rich in fibre and other medicinal phytochemicals hence could be a potential source for the development of antidiabetic nutraceutical. Subsequent to our earlier reports on the antidiabetic effects of various parts of exmaradi okra fruit, the current study was designed to develop appropriate formulation from the fruit seeds and peels. Various proportions of the powdered seeds and peels samples were thoroughly mixed in a ratio of 90:10; 80:20; 70:30; 60:40, 50:50%, respectively and vice-versa. The proximate composition and some functional properties viz: Antioxidant Capacity (AC), Water Adsorption Capacity (WAC), Oil Adsorption Capacity (OAC), Glucose Adsorption Capacity (GAC), Glucose Dialysis (GD), and Glucose Dialysis Retardation Index (GDRI) of each formulation were evaluated in-vitro. The results revealed that 10:90% (Seeds:Peels) formulation exhibited the highest significant (P < 0.05) percentage of Crude ash, fibre, and protein content; it also showed highest significant (P < 0.05) values for AC, WAC, OAC, GAC and GDRI as well as the lowest value for GD. Conclusively, the study showed that the 10:90% (Seeds:Peels) formulation has a
reduction effect the rate of glucose adsorption and diffusion and thus can retard increase in postprandial blood glucose level than the other combinations. Therefore, this combination was found to be the most suitable for the development of okra-based antidiabetic nutraceutical formulation for the management of diabetes mellitus.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
WHO. World Health Organization Global Report on Diabetes Mellitus. WHO, Geneva; (2016); (NLM classification: WK 810). 11-12 p.
Davis SN and Granner DK. Insulin, Oral Agents and the Pharmacology of the Endocrine Pancreas. In: Hardman JG, Limbird LE, Gilman AG (Eds.) The Pharmacological Basis of Therapeutics, Tenth ed. McGrandhill companies Incorp., New York, USA. 2001; 1679-1714 p.
Shaw JE, Sicree RA, Zimmet PZ. Global Estimates of the Prevalence of Diabetes for 2010 and 2030. 2010; Diab Res ClinPract. 87: 4-14.
King H, Aubert RE, Herman WH. Global Burden of Diabetes. 1995- 2025- Prevalence, Numerical estimates and Projections. Diabetes Care 1998; 21:1414-1431.
WHO. World Health Organization Study Group Report on Prevalence of Diabetes Mellitus. 2011; (WHO Technical Report Series No: 876).
Fujisawa T, Ikegami H, Inoue K, Kawabata Y, Ogihara T. Effect of Two α-glucosidase Inhibitors, Voglibose and Acarbose on Postprandial Hyperglycemia Correlates with Subjective Abdominal Symptoms. Met Clin Exp. 2005; 54(3): 387-390.
Hajera K, Ajijur R, Mohitosh B, Anwar Ul. Water-soluble Fraction of Abelmoschus esculentus L. Interacts with Glucose and Metformin Hydrochloride and Alters their Absorption Kinetics after Coadministration in Rats. ISRN Pharm. 2011;260537:5.
Sanjeet K, Sokona D, Adamou H, Alain R, Dov P, Christophe K. Okra (Abelmoschus spp.) in West and Central Africa: Potential and Progress on its Improvement. Afr J Agric Res.2010; 5(25):3590-3598.
Brower V. Nutraceuticals: Poised for a Healthy Slice of the Healthcare Market? Nat Biotech. 1999; 16:728-731.
Naveed A, Khan AA, Khan IA. Generation Mean Analysis of Water Stress Tolerance in Okra (Abelmoschus esculentus L.). Pak J Bot. 2009; 41:195-205.
Ndangui CB, Kimbonguila A, Nzikou JM, Matos L, Pambou NPG, Abena AA, Silou TH, Scher J, De-sobry S. Nutritive Composition and Properties Physico-chemical of Gumbo (Abelmoschus esculentu s L.) Seed and Oil. Res J Env Earth Sci. 2010; 2(1):49-54.
Adelakun, OE, Oyelade OJ, Ade-Omowaye, BIO, Adeyemi, IA, Van de Venter, M and Koekemoer TC. Influence of Pretreatment on Yield, Chemical and Antioxidant Properties of Nigerian Okra Seed (Abelmoschus esculentus Moench) Flour: J fct. 2008; 12:023.
Habtamu F, Gemede1 NR, Gulelat DH, Ashagrie ZW, Fekadu B. Nutritional Quality and Health Benefits of Okra (Abelmoschus esculentus): A Review. J Food Sci Qual Manag. 2014; 33:87-97.
Adetuyi F, Ajala L, Ibrahim T. Effect of the Addition of Defatted Okra Seed (Abelmoschus esculentus) Flour on the Chemical Composition, Functional Properties and Zn Bioavailability of Plantain (Musa paradisiacal linn) Flour. JMBFS. 2012; 2 (1): 69-82.
Andras CD, Simandi B, Orsi F, Lambrou C, Tatla DM, Panayiotou C, Domokos J, Doleschall F. Supercritical Carbondioxide Extraction of Okra (Hibiscus esculentus L.) Seeds. J Sci Food Agric. 2005; 85:1415-1419.
Muhammad I, Matazu KI, Yar’adua AI, Nasir A, Matazu NU, Zainab AS, AbdulRahman MB, Bilbis LS, Abbas AY.Antidiabetic Activity of Abelmoschus esculentus (Ex- Maradi Okra) Fruit in Alloxan- Induced Diabetic Rats. Nig J Biochem Mol Biol. 2017; 32(1):45-52.
AOAC. Association of Official Analytical Chemists Official Methods of Analysis, Food Composition, Additives and Natural Contaminants. Adrich RC (ed.) Vol 2, 15th ed Association of Official Analytical Chemist Inc. USA. 1990; 734-740 p.
McCune LM, Johns T. Antioxidant Activity in Medicinal Plants Associated with the Symptoms of Diabetes Mellitus used by the Indigenous Peoples of the North American Boreal Forest. J Ethnopharmacol. 2002; 82:197-205.
Athukorala Y, Kim KN, Jeon YJ. Antiproliferative and Antioxidant Properties of an Enzymatic Hydrolysate from Brown Alga Ecklonia Cava. Food Chem Toxicol. 2006; 44:1065-1074.
Oyaizu M. Studies of Products Browning Reaction; Antioxidant Activity of Products of Browning Reaction Prepared from Glucosamine. Jap J Nutr. 1986; 44:307-315.
Chau C, Cheung K, Wong, Y. Functional properties of protein concentrate from three Chinese indigenous legume seeds. J Agric Food Chem. 1997; 45:2500-2503.
Ou S, Kwok K, Li Y, Fu L. “In vitro Study of Possible Role of Dietary Fiber in Lowering Postprandial Serum Glucose,” J Agric Food Chem. 2001; 49:1026-1029.
Chau CF, Chen CH, Lee MH. Comparison of the Characterstics, Functional Propoties & in- vitro Hypoglycemic Effects of Various Carrots and Insoluble Fibre Rice Fractions. Lebensm-wis. U-Technol. 2004; 37:155-160.
Trinder P. Determination of Blood Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor. Ann Clin Biochem. 1969; 6:24-25.
Adiotomre J, Eastwood MA, Edwards CA, Brydon WG. Dietary Fiber: In-vitro Methods that Anticipate Nutrition and Metabolic Activity in Humans. Am J Clin Nutr. 1990;52(1):128-134.
WHO. World Health Organization Regional Committee, 52nd Session Brunei Darussalam. 2001; WPR/RC52/7.
Indah MA. Differential Expression Analysis of Diabetic Related Genes in Streptozotocin-Induced Diabetic Rat in Response to Abelmoschus esculentus Treatment: Int Conf Biosci Biochem Bioinfo. 2011; 5:43.
Sabitha V, Panneerselvam K, Ramachandran S. In-vitro αglucosidase and α-amylase Enzyme Inhibitory Effects in Aqueous Extracts of Abelmoscus esculentus (L.) Moench. Asian Pac J Trop Biomed. 2012; S162-S164.
John RT, Perez RJ, Baritua MO, Pacalna SO, Malayao J. Exploratory Investigation on the Hypoglycemic Effect of Abelmoschus esculentus in Mice. Int. J Sci Res. 2013. 1(2):249.
Shankul K. Physicochemical, Phytochemical and Toxicity Studies on Gum and Mucilage from Plant (Abelmoschus esculentus). J Phytopharmacol. 2014; 3(3):200-203.
Alozie YE, Iyam MA, Lawal O, Udofia U, Ani IF. Utilization of Bambara Ground Flour Blends in Bread Production. Ind JFood Technol. 2009; 7(4):111-114